Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 CAD | -5.26% |
|
+2.86% | -16.28% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 98% by 2026.
- The company shows low valuation levels, with an enterprise value at 0.39 times its sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.28% | 15.48M | - | ||
-4.43% | 253B | B | ||
+2.80% | 59.99B | B | ||
-18.30% | 59.84B | B- | ||
+1.16% | 53.08B | A- | ||
+8.33% | 43.99B | C | ||
+1.36% | 36.85B | B | ||
+118.22% | 28.61B | - | ||
-9.90% | 28.54B | B | ||
+5.15% | 22.03B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- PHA Stock
- Ratings Premier Health of America Inc.